|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.15 EUR | +3.51% |
|
-0.94% | +44.25% |
| 07-24 | Viatris Wins European Medicines Agency's Positive Opinion for Ruxolitinib Viatris | MT |
| 07-24 | Merck licenses experimental HIV pill to generic makers in 129 countries | RE |
Chart: Technical Analysis
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- VTRS Stock
- VTRS Stock
- Charts Viatris Inc.
Select your edition
All financial news and data tailored to specific country editions
